Resources & patient support

There is a range of information and support available for healthcare professionals and women with Nausea and Vomiting of Pregnancy.

Frequently asked questions

Support for healthcare professionals

There are a number of sources of information and guidelines available on the management of nausea and vomiting of pregnancy:

Pregnancy Sickness Support is a registered UK charity working to improve care, treatment and support for women suffering from Nausea and Vomiting in Pregnancy (NVP) and the severe form of the condition; Hyperemesis Gravidarum (HG).

Support for your patients

Information and support: The public section of this website provides information and support for women with nausea and vomiting of pregnancy.

Find out more Download Patient Leaflet

In particular, within the public site there is a page on ‘getting support’, which includes links to other websites and resources where women can find further information about nausea and vomiting of pregnancy.

Find out more


  1. Einarson A, Maltepe C, Boskovic R, Koren G. Treatment of nausea and vomiting in pregnancy. An updated algorithm. Can Fam Phys 2007; 53: 2109-2111.
  2. Association of Professors of Gynecology and Obstetrics. Nausea and Vomiting of Pregnancy. Continuing series on Women’s Health Education. 2011; Jespersen & Associates, LLC, Boston, Massachusetts.
  3. Royal College of Obstetricians and Gynaecologists. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum (Green-top Guideline No. 69). 22 June 2016. Royal College of Obstetricians and Gynaecologists: London.
  4. Severe vomiting in pregnancy. NHS Online. Last accessed Sept 2018.
  5. Crozier SR, Inskip HM, Godfrey K. Nausea and vomiting in early pregnancy: Effects on food intake and diet quality. Matern Child Nutr. 2017;13:e12389.
  6. Madjunkova S, Maltepe C, Koren G. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin®) for the treatment of nausea and vomiting of pregnancy. Pediatr Drugs 2014; 16: 199-211.
  7. Gadsby R, Barnie-Adshead T. Severe nausea and vomiting of pregnancy: should it be treated with appropriate pharmacotherapy. The Obstetrician & Gynaecologist 2011;13:107–111.
  8. Fairweather D V I. Nausea and Vomiting in Pregnancy.Am J Obstet Gynecol 1968; 102 (1): 135-175.
  9. Lee MD, et al. Gastroenterol Clin North Am. 2011 Jun; 40(2): 309–vii.
  10. Pregnancy week by week. Mayo Clinic. Last accessed August 2018.
  11. Xonvea 10 mg/10 mg gastro-resistant tablets Summary of Product Characteristics.
  12. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 189, January 2018. Nausea and vomiting of pregnancy. Obstet. Gynecol. 2018;131:e15-e30.
  13. Einarson T, Leeder J, Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharma 1988; 22(10):813-824.
  14. McKeigue P, Lamm S, Linn S, Kutcher J. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology 1994; 50(1): 27-37.
  15. Nulman I, Rovet J, Barrera M, et al. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and Diclectin. J Pediatr 2009; 155(1): 45-50, 50.e1-2.
  16. Holmes LB, Teratogen Update: 1983 Bendectin Teratology 83;27:277-8
  17. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
  18. Koren G. The return to the USA of the doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness– a new morning for American women. J Popul Ther Clin Pharmacol. 2013;20(2):e161-e162.
  19. Koren G, Clark S, Hankins GDV, Caritis SN, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. American Journal of Obstetrics & Gynaecology. 2010;203:571.e1–571.e7.
  20. Geiger CJ, Fahrenbach DM, Healey FJ. Bendectin in the treatment of nausea and vomiting in pregnancy. Obstet Gynecol. 1959;14:688–690.
  21. McGuinness BW, Binns DT. ‘Debendox’ in pregnancy sickness. J R Coll Gen Pract. 1971;21(109):500–503.
  22. Wheatley D. Treatment of pregnancy sickness. Br J Obstet Gynaecol. 1977;84(6):444–447.
  23. DESI 10598. Bendectin Peer Review Report, 14 March 1975. Overall Summary of ‘8-Way’ Bendectin Study, pp1-58  (Bendectin NDA-10-598).
  24. Harron DWG, Griffiths K, Shanks R G. Debendox and Congenital Malformations in Northern Ireland. BMJ 1980; 281: 1379-1381.
  25. Neutel CI. Variation in rates of hospitalisation for excessive vomiting in pregnancy by Bendectin/Diclectin use in Canada. Nausea and Vomiting of Pregnancy: State of the Art 2000. 54-59.
  26. BishaiR et al. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of Diclectin (doxylamine-B6). Can J ClinPharmacol. 2000;7(3):138-143.
  27. AtanackovicG et al. The safety of higher than standard dose of doxylamine pyridoxine for nausea and vomiting of pregnancy. J ClinPharmacol. 2001;41(8):842–845.
  28. Magee, LA et al. Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. Am J ObstetGynecol. 2002;186(5 SupplUnderstanding):S232-S238.
  29. BoskovicR et al. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J ObstetGynaecolCan. 2003;25(10):830–833.
  30. Kutcher, J et al. Bendectinand Birth Defects II: Ecological Analyses. Birth Defects Res (Part A: Clin Mol Teratol). 2003;67:88-97.
  31. Reeve BK, et al. Prophylactic Diclectin reduces the incidence of postoperative vomiting. Can J Anesth. 2005;52(1):55-61.
  32. Costantine MM, Matok I, Chiossi G, Clark S, Miodovnik M, Umans JG, et al. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Ther Drug Monit. 2012;34(5):569–573.
  33. MaltepeC et al. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum -a 2013 update. J PopulTherClin Pharmacol. 2013;20:e184-e192.
  34. Ashkenazi-Hoffnung. L et al. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylaminefor nausea and vomiting of pregnancy. IsrMed AssocJ. 2013 Jan;15(1):23-26.
  35. Pope E et al. Comparing pyridoxine and doxylaminesuccinate-pyridoxine HClfor nausea and vomiting of pregnancy: a matched, controlled cohort study. J. Clin. Pharmacol. 2015;55(7):809–814.
  36. The safety of Diclectin in breastfeeding. MSC Thesis (2015). Department of Pharmacology and Toxicology University of Toronto.
  37. O’Donnell A et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment. Health TechnolAssess. 2016;20(74):1-268.
  38. O’Doherty K, Craven S, Higgins M et al. ‘If I didn’t know this existed, I wouldn’t conceive again’. A 360 assessment of the clinical effectiveness of pyridoxine-doxylamine in the management of nausea and vomiting of pregnancy. Poster PM.022 presented at: 20th Annual conference of the British Maternal and Fetal Medicine Society; 2018 19-20 April; Brighton, UK [BJOG 2018;125(Suppl. 2):62].
  39. Gadsby R et al. Nausea and vomiting of pregnancy and resource implications: The NVP Impact Study. Br J Gen Pract. 2018. Manuscript submitted for publication.
  40. NICE (March 2008; updated Jan. 2017). Antenatal care for uncomplicated pregnancies (Clinical Guideline (CG) 62). National Institute for Health and Care Excellence. HYPERLINK “”
  41. Mitchell-Jones N, et al. Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm. BMJ Open 2017;7:e017566. doi:10.1136/bmjopen-2017-017566.
  42. Dean C, Marsden J. MIDIRS Midwifery Digest, vol 27, no 1, March 2017, pp 11-20.
  43. Ebrahimi N et al. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803–807.